Sacroiliac Joint Fusion Surgery

Global Sacroiliac Joint Fusion Surgery Market to Reach US$1.0 Billion by 2030

The global market for Sacroiliac Joint Fusion Surgery estimated at US$340.1 Million in the year 2024, is expected to reach US$1.0 Billion by 2030, growing at a CAGR of 19.9% over the analysis period 2024-2030. Degenerative Sacroiliitis, one of the segments analyzed in the report, is expected to record a 21.4% CAGR and reach US$743.1 Million by the end of the analysis period. Growth in the Sacral Disruption segment is estimated at 16.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$92.7 Million While China is Forecast to Grow at 26.3% CAGR

The Sacroiliac Joint Fusion Surgery market in the U.S. is estimated at US$92.7 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$231.8 Million by the year 2030 trailing a CAGR of 26.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 14.6% and 18.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 15.9% CAGR.

What Is Sacroiliac Joint Fusion Surgery and Why Is It Becoming a Preferred Option for Chronic Pelvic Pain?
Sacroiliac (SI) joint fusion surgery is a minimally invasive or open surgical procedure designed to treat chronic dysfunction or instability of the sacroiliac joint—the joint that connects the base of the spine (sacrum) to the pelvis (ilium). This joint plays a critical role in absorbing shock and transferring loads between the upper body and lower limbs. SI joint dysfunction can cause severe lower back, pelvic, and leg pain, often mimicking symptoms of sciatica or discogenic pain. When conservative treatments such as physical therapy, injections, or radiofrequency ablation fail, surgical fusion becomes a viable long-term solution.

The procedure involves the placement of screws, cages, or implants—often using a lateral or posterior approach—to stabilize the joint and encourage bone growth for permanent fusion. Minimally invasive SI joint fusion, which is performed with fluoroscopic or CT guidance, has gained traction due to its reduced operative time, smaller incisions, less blood loss, and faster recovery. The surgery significantly improves pain relief, functional mobility, and quality of life for patients suffering from debilitating SI joint disorders, particularly those with trauma, degeneration, postpartum instability, or prior lumbar fusion.

What Innovations Are Enhancing the Precision and Outcomes of SI Joint Fusion Procedures?
The sacroiliac joint fusion market is rapidly evolving with technological advancements aimed at improving surgical accuracy, minimizing complications, and accelerating recovery. Minimally invasive techniques have become the gold standard, driven by the development of percutaneous fusion systems that require only a small incision and fluoroscopy-assisted implant placement. These systems reduce hospital stays, minimize tissue disruption, and enable same-day discharge in many cases. 3D imaging and intraoperative navigation technologies are being increasingly integrated into surgical workflows, allowing for more precise placement of implants and real-time confirmation of fusion device positioning.

Implant design has seen significant innovation, with manufacturers introducing porous titanium-coated implants, 3D-printed devices, and bone grafting materials that enhance osteointegration and long-term joint stability. Some implants now feature specialized surface textures or coatings that promote bone in-growth and reduce the risk of loosening. Robotic-assisted surgery is also being explored to improve reproducibility and accuracy in complex or anatomically challenging cases.

In addition, post-operative protocols are being optimized through enhanced recovery after surgery (ERAS) pathways, which include multimodal pain management, early ambulation, and patient education to speed up recovery and reduce complication rates. These improvements are encouraging broader surgeon adoption and making SI joint fusion more accessible to patients earlier in their treatment continuum.

Which Patient Groups and Clinical Trends Are Expanding the Scope of SI Joint Fusion?
The demand for SI joint fusion surgery is growing across several demographic and clinical segments. Middle-aged and elderly populations are the primary patient base, especially those with degenerative sacroiliitis, pelvic instability, or a history of spinal fusion. Studies show that a significant portion of post-lumbar fusion patients develop SI joint dysfunction due to altered biomechanics, leading to increased referrals for SI joint evaluation and potential fusion. Women—particularly postpartum patients—are also disproportionately affected due to hormonal changes and increased pelvic stress during childbirth.

Furthermore, trauma-related SI joint injuries, inflammatory joint diseases, and anatomic abnormalities are leading to earlier diagnosis and surgical intervention. Advances in diagnostic imaging and clinical awareness are helping physicians differentiate SI joint pain from lumbar spine disorders, resulting in more accurate and timely treatment pathways. Patients with chronic lower back pain who fail to respond to traditional therapies are increasingly being evaluated for SI joint pathology as a primary or secondary cause.

Healthcare providers and payers are also recognizing the cost-effectiveness of SI joint fusion in select patients, as it reduces long-term pain management costs, improves mobility, and enables a return to work or daily activity. As patient-reported outcome measures (PROMs) and value-based healthcare models become more prominent, sacroiliac joint fusion surgery is emerging as a clinically validated and economically viable treatment option.

What Is Fueling the Growth of the Global Sacroiliac Joint Fusion Surgery Market?
The growth in the global sacroiliac joint fusion surgery market is driven by several factors, including increasing prevalence of chronic lower back and pelvic pain, expanding clinical acceptance of SI joint pathology, and technological advancements in minimally invasive surgical devices. Rising awareness among orthopedic and spine specialists, along with the development of specialized diagnostic algorithms, is resulting in more accurate diagnosis and earlier surgical referrals.

Innovations in implant design, robotic navigation, and outpatient surgical techniques are improving clinical outcomes, reducing hospital costs, and shortening recovery time—further enhancing patient and provider confidence. The growing demand for less invasive orthopedic procedures and the global shift toward ambulatory care models are also contributing to market growth, particularly in North America and Europe.

Moreover, favorable reimbursement policies in developed markets, increased availability of specialized training programs, and strategic investments by medical device manufacturers are accelerating procedure adoption. Emerging markets in Asia-Pacific and Latin America are beginning to show growth potential as healthcare infrastructure improves and spinal care awareness spreads. With a strong convergence of clinical demand, surgical innovation, and patient-centered care models, the sacroiliac joint fusion surgery market is poised for sustained expansion globally.

SCOPE OF STUDY:

The report analyzes the Sacroiliac Joint Fusion Surgery market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Indication (Degenerative Sacroiliitis, Sacral Disruption); Type (MIS, Open); Approach (Dorsal & Anterior, Lateral); Product (Implants, Accessories); End-Use (Hospitals, Ambulatory Surgery Centers, Others)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 37 Featured) -

• Alphatec Spine, Inc.
• Camber Spine Technologies, LLC
• CoreLink Surgical
• CornerLoc
• DePuy Synthes (Johnson & Johnson)
• Globus Medical, Inc.
• Integra LifeSciences Holdings Corp.
• Life Spine, Inc.
• Medtronic plc
• Nevro Corp.
• NuVasive, Inc.
• Orthofix Medical Inc.
• PainTEQ
• SI-BONE, Inc.
• SIGNUS Medizintechnik GmbH
• Tenon Medical, Inc.
• VYRSA Technologies
• Xtant Medical Holdings, Inc.
• Zimmer Biomet Holdings, Inc.
• Zyga Technology, Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.